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Intracellular amastigotes of the protozoan parasite
Leishmania mexicana secrete a macromolecular proteo-
phosphoglycan (aPPG) into the phagolysosome of their
host cell, the mammalian macrophage. The structures of
aPPG glycans were analyzed by a combination of high
pH anion exchange high pressure liquid chromatogra-
phy, gas chromatography-mass spectrometry, enzy-
matic digestions, electrospray-mass spectrometry as
well as 1H and 31P NMR spectroscopy. Some glycans are
identical to oligosaccharides known from Leishmania
mexicana promastigote lipophosphoglycan and se-
creted acid phosphatase. However, the majority of the
aPPG glycans represent amastigote stage-specific and
novel structures. These include neutral glycans ([Glcb1–
3]1–2Galb1–4Man, Galb1–3Galb1–4Man, Galb1–3Glcb1–
3Galb1–4Man), several monophosphorylated glycans
containing the conserved phosphodisaccharide back-
bone (R-3-[PO4-6-Gal]b1–4Man) but carrying stage-spe-
cific modifications (R 5 Galb1-, [Glcb1–3]1–2Glcb1-), and
monophosphorylated aPPG tri- and tetrasaccharides
that are uniquely phosphorylated on the terminal hex-
ose (PO4-6-Glcb1–3Galb1–4Man, PO4-6-Glcb1–3Glcb1–
3Galb1–4Man, PO4-6-Galb1–3Glcb1–3Galb1–4Man). In
addition aPPG contains highly unusual di- and triphos-
phorylated glycans whose major species are PO4-6-
Glcb1–3Glcb1–3[PO4-6-Gal]b1–4Man, PO4-6-Galb1–3Glcb
1–3[PO4-6-Gal]b1–4Man, PO4-6-Galb1–3Glcb1–3Glcb1–3
[PO4-6-Gal]b1– 4Man, PO4-6-Glcb1–3[PO4-6-Glc]b1–3
[PO4-6-Gal]b1–4Man, PO4-6-Galb1–3[PO4-6-Glc]b1–3Glc-
b1–3[PO4-6-Gal]b1–4Man, and PO4-6-Glcb1–3[PO4-6-Glc-
]b1–3Glcb1–3[PO4-6-Gal]b1–4Man. These glycans are
linked together by the conserved phosphodiester R-Man-
a1-PO4-6-Gal-R or the novel phosphodiester R-Mana1-
PO4-6-Glc-R and are connected to Ser(P) of the protein
backbone most likely via the linkage R-Mana1-PO4-Ser.
The variety of stage-specific glycan structures in
Leishmania mexicana aPPG suggests the presence of
developmentally regulated amastigote glycosyl-
transferases which may be potential anti-parasite drug
targets.
Protozoan parasites of the genus Leishmania are the causa-
tive agent of a spectrum of human diseases. Leishmania have a
digenetic life cycle that encompasses the extracellular promas-
tigotes in the digestive tract of the parasite-transmitting insect
vector, the sandfly, and the disease-causing intracellular
amastigotes living in parasitophorous vacuoles of mammalian
macrophages.
The parasites produce unusual glycoconjugates, which are
thought to play crucial roles for survival, development, and
virulence in both developmental stages of the parasite. The
best characterized Leishmania glycoconjugate is the promas-
tigote cell-surface glycolipid, lipophosphoglycan (LPG).1 The
structure of LPG from five different Leishmania species has
been determined. LPG contains a conserved lyso-alkylphos-
phatidylinositol membrane anchor linked to a phosphohexa-
saccharide core structure, a conserved backbone of up to 40
phosphodiester-linked disaccharide repeats (PO4-6-Galb1–
4Mana1-), and species-, strain-, and stage-specific components
linked to the core and repeats as well as terminating neutral
(cap) glycans at the non-reducing end of the molecule (reviewed
in Refs. 1 and 2). In the sandfly, LPG serves as a ligand for the
attachment of non-infectious procyclic promastigotes to the
midgut wall lining and may protect the parasites against the
hydrolytic environment of the insect’s digestive tract. A stage-
specific form of LPG confers complement resistance to the
highly infectious metacyclic promastigotes, which are injected
by the sandfly into the skin of the mammalian host. LPG also
acts as a receptor for the invasion of macrophages by metacyclic
promastigotes and may protect this transient mammalian par-
asite stage against the initial microbicidal response of the host
cell by acting as a radical scavenger and by modulating signal
transduction and gene expression of the macrophage (reviewed
in Refs. 3–5). Structure-function analysis of LPG and its frag-
ments demonstrated the importance of the glycolipid anchor,
the phosphoglycan chains, and the cap oligosaccharides for
these functions (6–13). The biosynthetic pathway of LPG has
been partially elucidated and has been implicated as a poten-
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tial target for the development of chemotherapeutic agents
(14–20).
Although the crucial role of LPG for the promastigote stages
of Leishmania is well established, its importance for the dis-
ease-causing amastigote stage in the mammalian host is less
clear. Leishmania donovani and Leishmania mexicana
amastigotes do not express LPG (21, 22). Leishmania major
amastigotes synthesize low levels of a stage-specific LPG (23–
25), which may be involved in host cell binding and uptake (26),
but amastigote LPG does not form a protective surface glyco-
calyx like in promastigotes (27).
It has been demonstrated that some of the biologically active
structural elements of LPG like the repetitive phosphoglycans
and the neutral cap oligosaccharides are also present on Leish-
mania promastigote proteins like acid phosphatase (sAP) (28–
33) and the filamentous proteophosphoglycan of promastigotes
(pPPG) (32, 34). In these molecules, the glycans are linked to
the protein backbone via phosphoserine residues (33, 34), a
form of protein glycosylation not yet observed in mammalian
cells. Recently, it has been shown that protein-bound phospho-
glycans are also present in the amastigote stage of L. mexicana
(22, 35). This amastigote proteophosphoglycan (aPPG) is se-
creted by the parasites in large amounts into the phagolyso-
somes of host macrophages, where it may accumulate to mg/ml
concentrations (35). The massive secretion of aPPG by amastig-
otes may contribute to the expansion of the phagolysosomes to
huge parasitophorous vacuoles, which are the hallmark of L.
mexicana infections (36). It has also been demonstrated that L.
mexicana aPPG is an activator of the complement cascade via
the lectin pathway. This property may contribute to lesion
development and pathology caused by L. mexicana (37). A
preliminary analysis of aPPG showed that it is immunologi-
cally and chemically related to the promastigote phosphoglycan
antigens LPG and sAP but also exhibits distinct properties
(35).
In the present study we describe the structural analysis of
the glycans from L. mexicana aPPG purified from infected
mouse lesion tissue. We demonstrate that, in addition to oligo-
saccharides also present in L. mexicana promastigote phospho-
glycan antigens, aPPG contains a variety of stage-specific neu-
tral and phosphorylated glycans. These glycans are linked
together by phosphodiester bonds and are most likely con-
nected to the protein backbone via phosphoserine residues. We
also show that a large proportion of aPPG glycans is modified
by two, three, or even four phosphate groups in diester linkages
to other glycans.
EXPERIMENTAL PROCEDURES
Parasites—L. mexicana promastigotes (strain MNYC/BZ/62/M379)
were grown in semi-defined medium 79 as described (38). L. mexicana
amastigote-infected tissue was obtained from dorsal lesions of CBA
mice infected 3–6 months previously with 5 3 106 stationary phase
promastigotes in the shaven rump at the base of the tail.
Purification of Phosphoglycan Antigens and Analytical Proce-
dures—L. mexicana aPPG was purified from infected mouse tissue as
described earlier (35) with the modifications reported recently (36).
Purification of L. mexicana LPG, sAP, PG, pPPG, and L. major pPPG
from promastigote culture supernatant was performed as described
previously (33, 34, 39).
Analytical Techniques—Colorimetric carbohydrate, protein, and
phosphate analysis, mild acid hydrolysis, 40% HF dephosphorylation,
phosphoamino acid analysis, and SDS-polyacrylamide gel electrophore-
sis were performed as outlined previously (31, 33, 34, 39). Carbohydrate
in Superose 6 fractions was detected semi-quantitatively by spotting
1-ml aliquots onto Silica Gel 60 plates (Merck, Darmstadt, FRG) fol-
lowed by reaction with orcinol/H2SO4 (39). Two-site ELISA using the
monoclonal antibody AP3 as trapping antibody was also performed as
described before (35), except for using biotinylated AP3 followed by
Extravidin coupled to calf intestine alkaline phosphatase (AP) (Sigma,
Deisenhofen, FRG) or LT22 followed by goat anti-mouse IgG (g-chain-
specific) antibodies coupled to AP (Sigma) as detection systems. Com-
bined gas chromatography-mass spectometry (GC-MS) was performed
using a Hewlett-Packard HP6859 GC-MS, fitted with either a 25-m 3
0.3-mm CPSil5 low polarity column (Chrompack, Middleburg, The
Netherlands) for trimethylsilyl derivatives and permethylated alditol
acetates or a 25-m 3 0.22-mm BPX-70 high polarity column (SGE,
Ringwood, Australia) for alditol acetates and permethylated alditol
acetates as described previously (34). Amino acid analysis and N-ter-
minal protein sequencing were performed on automated systems (Ap-
plied Biosystems, models 420A and 477A, respectively) according to the
manufacturer’s protocols.
Enzyme Treatment of Glycans—Neutral glycans were treated with
sweet almond b-glucosidase (SABG, Boehringer Mannheim, FRG, 40
units/ml), jack bean a-mannosidase (JBAM, Sigma, 10 units/ml), or
bovine testes b-galactosidase (BTBG, Boehringer Mannheim, 0.2 units/
ml) in 10 mM sodium acetate, pH 4.5, for 16 h at 37 °C. Dephosphoryl-
ation of phosphoglycans by AP (50 units/ml) was performed in 20 mM
NH4HCO3 for 4–16 h at 37 °C. Samples were either desalted (34) or
diluted 1:20 and then rechromatographed by high pH anion exchange
HPLC (HPAE-HPLC).
Monosaccharide and Methylation Analysis—Native and mild acid-
hydrolyzed aPPG (10 mg) containing myo-inositol as an internal stand-
ard and monosaccharide standards were subjected to methanolysis,
re-N-acetylated, and following trimethylsilylation analyzed by GC-MS
either directly or after methylation with diazomethane (40) as described
previously (25, 39). Alternatively, neutral monosaccharides of aPPG
and of purified oligosaccharides (0.5–10 mg) were also determined as
alditol acetates prepared and analyzed by standard methods (41). To
quantitate neutral and phosphorylated monosaccharides in L. mexi-
cana sAP and L. mexicana aPPG, samples (10 mg) were hydrolyzed in 2
M trifluoroacetic acid for 2 h at 105 °C. This treatment cleaves most
glycosidic bonds involving pentoses and hexoses quantitatively (41),
whereas the phosphomonoester bonds of hexose 6-phosphates are sta-
ble. The resulting neutral and phosphorylated monosaccharides were
separated by HPAE-HPLC using program 8 (see below). Pooled frac-
tions were desalted by passage over AG50 3 12 (H1) and lyophilized;
myo-inositol was added as an internal standard, and the phosphoryl-
ated glycans were dephosphorylated by AP treatment (see above). The
resulting monosaccharides were reduced, acetylated, and analyzed as
alditol acetates by GC-MS and quantitated relative to the internal
standard. Methylation linkage analysis of dephosphorylated glycans
(0.5–5 mg) was performed as described previously (25, 39, 43).
High pH Anion Exchange HPLC—Neutral and phosphorylated gly-
cans released from L. mexicana aPPG by mild acid hydrolysis or 40%
HF treatment were separated by high pH anion exchange HPLC on a
Dionex BioLC carbohydrate analyzer (Dionex Corp. Sunnyvale, CA)
using a Carbo-Pac PA1 column and pulsed amperometric detection
using linear gradients of sodium acetate in 150 mM NaOH. Several
gradient programs were used as follows: program 1, 0 mM for 6 min,
raised to 50 mM over 18 min, to 125 mM over 7 min, and held at 125 mM
for 14 min; program 2, program 1 followed a raise of the sodium acetate
concentration to 175 mM over 3 min, to 250 mM over 30 min, held at 250
mM for 10 min, raised to 625 mM over 10 min, and held at 625 mM for 5
min; program 3, 0 mM for 6 min, raised to 50 mM over 18 min, to 125 mM
over 21 min, and held at 125 mM for 15 min; program 4, 250 mM for 6
min, raised to 1000 mM over 1 min, and held at 1000 mM for 13 min;
program 5, 250 mM for 6 min, raised to 385 mM over 1 min, held at 385
mM for 18 min, raised to 625 mM over 1 min, and held at 625 mM for 10
min; program 6, isocratic, 385 mM for 20 min; program 7, 385 mM for 15
min, raised to 625 mM over 30 min, and held at 625 mM for 10 min. For
the separation of hexoses from hexose phosphates, the Carbo-Pac PA1
column was held at 100 mM NaOH for 10 min; NaOH and NaAc were
then raised to 150 and 187.5 mM, respectively, over 2 min and held at
that concentration for 18 min (program 8).
Electrospray Ionization-Mass Spectrometry (ES-MS)—Mass spectra
of oligosaccharides were acquired on a Finnigan LCQ ES-MS. Samples
were introduced into the electrospray source through a rheodyne injec-
tor with a 5-ml loop at a flow rate of 5 ml/min in either 25% methanol in
H2O for native oligosaccharides or 50% aqueous acetonitrile for per-
methylated oligosaccharides. Mass spectra were acquired both in the
negative and the positive ion mode using the following conditions. The
heated capillary was set to 170 °C; the maximum trapping time was 500
ms; the capillary, tube lens, and needle voltages were 25, 50, and 4.5 V,
respectively, and the number of microscans was set to 1. MS-MS scans
were performed by trapping the ion of interest and ejecting all other
ions outside a 3-atomic mass unit window centered around the parent
ion. Collision energy was set such that the parent ion was attenuated
between 95 and 99%. Data were collected as averages of four spectra.
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NMR Spectroscopy—NMR spectra were recorded in D2O on Bruker
ARX 500 or DMX 750 spectrometers for the intact aPPG, LPG, and a
range of neutral and phosphorylated fragment glycans. Most spectra
were recorded at 288 K, but selected spectra were also recorded at
temperatures in the range 296 to 310 K to check for the presence of
anomeric signals coincident with the residual solvent resonance. Spec-
tra included one-dimensional 1H and 31P NMR, two-dimensional 1H-1H
TOCSY, double quantum-filtered correlation spectroscopy, nuclear
Overhauser effect spectroscopy, rotating-frame nuclear Overhauser ef-
fect spectroscopy spectra, and 31P-1H HMBC spectra. Some 1H spectra
of phosphorylated glycans were recorded in the presence and absence of
31P decoupling. The one- and two-dimensional 31P spectra were re-
corded at 202 MHz, whereas all 1H NMR spectra were recorded at
either 500.13 or 750.13 MHz. One-dimensional 1H spectra at 500 MHz
were recorded with a spectral width of 5050 Hz, a pulse length of 7.5 ms
(60°), and a relaxation delay between scans of 3 s. Similar conditions
were used for the spectra recorded at 750 MHz. Typically 256–512
scans, for weaker samples up to several thousand scans, were accumu-
lated. Mild presaturation was used to suppress the residual HOD signal
from the D2O solvent. Spectra were processed using an exponential line
broadening function of 0.3 Hz. Chemical shifts are referenced to 2,2-
dimethyl-2-silapentane-5-sulfonate at 0.00 ppm. One-dimensional 31P
spectra were recorded with a spectral width of 5000 Hz, a pulse width
of 5 ms (45°), and a relaxation delay between scans of 2 s. Typically 500
scans were acquired prior to Fourier transformation. Spectra were
processed using an exponential line broadening function of 5–10 Hz.
Chemical shifts were referenced to an external capillary of neat H3PO4
at 0.00 ppm. All two-dimensional homonuclear 1H spectra were re-
corded at 750 MHz, typically with spectral widths of 2500 Hz in both
dimensions, 4K data points in frequency dimension F2 and 256–800
increments in F1, each of 16–256 scans. TOCSY spectra were recorded
with a mixing time of 80 ms, while for nuclear Overhauser effect
spectroscopy and rotating-frame nuclear Overhauser effect spectros-
copy of selected glycans the mixing times were 300 and 250 ms, respec-
tively. In most cases gradient pulses using the Watergate sequence (42)
were used to suppress the residual solvent resonance, but in selected
cases presaturation was used. The two-dimensional data were pro-
cessed as a 4094 3 2048 data matrix, generally using shifted sine-bell
apodization functions in both dimensions. HMBC spectra were recorded
using 2048 complex data points in F2. A total of 32 scans was recorded
for each of 128 slices over a spectral width of 800 Hz in F1. A relaxation
delay of 1.0 s was used between scans, with an evolution delay of 50 ms
in the HMBC sequence, as described previously (34). The two-dimen-
sional data were processed as a 2048 3 1024 matrix, with a squared
sine bell window function applied in both dimensions.
RESULTS
L. mexicana aPPG Glycans Are Linked to Phosphoserine of
the Protein Backbone via Mild Acid-labile Phosphodiester
Bonds—L. mexicana aPPG purified from amastigote-infected
mouse lesion tissue eluted on a Superose 6 gel filtration column
as a broad peak between the 2000 and the 440 kDa markers as
detected by phosphate and carbohydrate determination as well
as two-site ELISA (Fig. 1A). On SDS-polyacrylamide gels aPPG
FIG. 1. Superose 6 gel filtration chromatography of L. mexi-
cana aPPG. Purified aPPG before (A) and after mild acid hydrolysis
(B) was chromatographed on Superose 6 in 250 mM ammonium acetate.
Fractions were monitored for phosphate and for reactivity to the mAbs
AP3 and LT22 in a two-site ELISA. Glycan was determined semi-
quantitatively by reaction with orcinol/H2SO4 on TLC plates. The dot
size indicates the relative intensity of staining. The elution positions of
dextran blue (2000 kDa), thyroglobulin (667 kDa), ferritin (440 kDa),
transferrin (80 kDa), and the inclusion volume (Vt, CTP) of the column
are indicated. The fraction size was 1 ml.
FIG. 2. Analysis of native, mild acid-hydrolyzed, and AP-
treated L. mexicana aPPG by SDS-polyacrylamide gel electro-
phoresis. A, lane 1, L. mexicana aPPG (5 mg); lanes 2 and 4, L.
mexicana aPPG (5 mg) after mild acid hydrolysis; lanes 3 and 5, L.
mexicana aPPG (5 mg) after mild acid hydrolysis and AP treatment;
lane 6, AP control. Lanes 1–3 were stained with Stains-all and lanes
4–6 with Coomassie Blue. B, analysis of Superose 6 fractions of native
aPPG (fractions 7–19, 10 ml each; Fig. 1A). C, analysis of Superose 6
fractions of mild acid-hydrolyzed aPPG (fractions 7–20, 10 ml each; Fig.
1B). Gels B and C were stained with Stains-all. The position of standard
proteins and their molecular mass in kDa is indicated by solid arrows.
The open arrows indicate the start of the gels.
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was detected in positive fractions as a smear migrating above
the 200-kDa marker protein (Fig. 2A, lane 1 and Fig. 2B, lanes
9–14). After mild acid hydrolysis, known to be selective for
hexose 1-phosphate bonds (43, 44), the high molecular weight
aPPG (Fig. 2A, lane 1) disappeared on SDS-polyacrylamide
gels, and a series of polypeptide bands between 40 kDa and the
gel front were detected (Fig. 2A, lane 2). In Superose 6 chro-
matography, the majority of the carbohydrate (.95%) and
phosphate (.90%) of mild acid-treated aPPG was found near
the inclusion volume (Vt) of the column with small amounts of
phosphate and traces of glycans in a second earlier eluting
peak (Fig. 1B, fractions 15–18). This peak contained the
polypeptides released by mild acid (Fig. 2C, lanes 15–19), which
were pooled and subjected to amino acid analysis and protein
sequencing. The amino acid composition of the pooled polypep-
tides (2.8% Asp/Asn, 5.7% Glu/Gln, 28.9% Ser, 11% Gly, 3.3%
His, 1.2% Arg, 9.9% Thr, 9.7% Ala, 7.7% Pro, 1.6% Tyr, 4.9%
Val, 2.1% Ile, 3.7% Leu, 6.9% Phe, and 0.6% Lys) was similar to
the published composition of intact aPPG (35), which suggests
that they correspond to the deglycosylated aPPG protein back-
bone. N-terminal sequencing of the pooled polypeptides and
one of the Superose 6 fractions (Fig. 2C, fraction 16) showed in
both analyses the peptide sequence NPIFXXD (where X indi-
cates ambiguities). This indicates that despite the complex
pattern on SDS-polyacrylamide gels (Fig. 2A, lanes 2 and 4 and
Fig. 2C, lanes 15–19), the aPPG protein backbone may be
formed by either one or several closely related polypeptide
species. Phosphoamino acid analysis showed that only serine
residues are phosphorylated (.25%). Phosphoserine in aPPG
was resistant to mild acid deglycosylation and to AP treatment,
whereas the consecutive application of both treatments led to
the loss (.90%) of the phosphorylated amino acid. On SDS-
polyacrylamide gels, the polypeptides obtained after mild acid
deglycosylation of aPPG were readily visualized by the cationic
dye Stains-all (Fig. 2A, lane 2) with an intense blue color, and
after dephosphorylation no staining occurred (Fig. 2A, lane 3).
Coomassie Blue staining of the same gel revealed the dephos-
phorylated polypeptides between 65 and 50 kDa apparent mo-
lecular mass (Fig. 2A, lane 5). Taken together the results indi-
cated that the majority of aPPG glycans are linked to a serine-
rich protein backbone via mild acid labile phosphodiester bonds
to serine. This interpretation was corroborated by 31P NMR
spectroscopy, which shows that phosphate is exclusively pres-
ent in diester linkages in intact aPPG (see below).
The Majority of the Mild Acid Labile L. mexicana aPPG
Glycans Are Stage-specific—The mild acid-released aPPG gly-
cans (Fig. 1B, fractions 20–24) were separated by HPAE-HPLC
under conditions which resolve neutral, monophosphorylated,
and multiply phosphorylated glycans (Fig. 3C). Mild acid-re-
leased glycans of L. mexicana promastigote LPG (Fig. 3A) and
FIG. 3. HPAE-HPLC profiles of L.
mexicana LPG, sAP, and aPPG gly-
cans released by mild acid hydroly-
sis. Neutral (N) and phosphorylated (P)
glycans from mild acid-treated L. mexi-
cana LPG (A), sAP (B), and aPPG (C)
were resolved on a Carbo-Pac PA1 column
using the gradient program 2. # depicts
non-carbohydrate peaks; * is a peak con-
taining some partial hydrolysis glycan
products of LPG, sAP, and aPPG and pos-
sibly also non-carbohydrate compounds
and was not further analyzed. Diphospho-
rylated aPPG glycans (Di-P fraction of
Fig. 4C) were partially resolved on a Car-
bo-PacPA1 column using gradient pro-
gram 6 (D), whereas triphosphorylated
and tetraphosphorylated glycans (Tri-P
and Tetra-P, Fig. 4C) were partially re-
solved on the same column using gradient
program 7 (E).
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sAP (Fig. 3B) served as standards and were resolved under
identical conditions. Whereas L. mexicana aPPG contains the
entire set of cap glycans and monophosphorylated glycans pre-
viously identified in LPG and sAP, the majority of its oligosac-
charides are amastigote stage-specific and not detected in the
promastigote phosphoglycan antigens.
Structural Analysis of the Neutral Cap Oligosaccharides and
the HF-dephosphorylated Oligosaccharide Backbones of L.
mexicana aPPG—The mild acid-released neutral aPPG cap
oligosaccharides and the neutral glycans obtained by 40% HF
dephosphorylation of intact aPPG (corresponding to the entire
set of oligosaccharide backbones) were isolated for structural
analysis by HPAE-HPLC (compare Fig. 3C (0–48 min) and Fig.
4A, respectively). Their structures were determined by mono-
saccharide analysis, methylation linkage analysis, ES-MS (Ta-
ble I), exoglycosidase digests (Table I, compare also Fig. 4, B
and C), and coelution with authentic standards (Fig. 3, A and
B). The results are summarized in Table II; Man,2 the manno-
oligosaccharide series N2a-N6a ((Mana1–2)1–5Man), N2b
(Galb1–4Man), and N3c (Glcb1–3Galb1–4Man) are known
components of L. mexicana promastigote LPG and sAP (33, 39).
N3b (Galb1–3Galb1–4Man) and N4c (Glcb1–3Glcb1–3Galb1–
4Man) were previously identified in L. major and Leishmania
tropica LPG (2, 43) but not in L. mexicana glycoconjugates.
N4b, N5b-d, N6b, and N6c, however, represent completely
novel glycan backbones. BTBG digestion (product N3c), SABG
digestion3 (product N2b), ES-MS of permethylated samples,
and methylation analysis of N4b resulted in the proposed struc-
ture Galb1–3Glcb1–3Galb1–4Man (Tables I and II, Fig. 4).
The same analysis of N5b and N5d suggested the structures
Galb1–3Glcb1–3Glcb1–3Galb1–4Man and Glcb1–3Glcb1–
3Glcb1–3Galb1–4Man, respectively. N5c may be either Glcb1–
3Galb1–3Glcb1–3Galb1–4Man or Glcb1–3Glcb1–3Galb1–
3Galb1–4Man, which cannot be distinguished by the methods
used. A similar situation arises with N6b and N6c, which have
most likely the structure Glcb1–3Hexb1–3Hexb1–3Hexb1–
3Galb1–4Man, where two of the hexoses are Glc and one is Gal
(Tables I and II, Fig. 4). The dominant glycan backbone in
aPPG is N4c followed by Man, N2b, N4b, and N3c. In contrast
in the two promastigote phosphoglycan antigens L. mexicana
LPG and sAP, N2b and N3c are the major glycans (70–90 mol
%; Table II and Ref. 33). Stage-specific backbone structures
(N3b, N4b,c, N5b-d, N6b and -c) not previously observed in
either of the promastigote glycoconjugates form the majority of
the aPPG glycans (.55 mol %).
L. mexicana aPPG Contains Gal-6-PO4 and Glc-6-PO4—
Phosphohexose analysis of L. mexicana aPPG was performed
using L. mexicana sAP as a reference compound. Qualitative
analysis (GC-MS) showed that aPPG contains both Gal-6-PO4
and Glc-6-PO4, whereas sAP contains only Gal-6-PO4. None of
the samples contained Man-6-PO4. To quantitate the degree of
hexose phosphorylation in the two compounds, aPPG and sAP
were hydrolyzed in 2 M trifluoroacetic acid; neutral and phos-
phorylated monosaccharides were separated by HPAE-HPLC
and their compositions were analyzed after AP digestion, re-
duction, and acetylation as alditol acetates by GC-MS (Fig. 5).
L. mexicana sAP contained only Gal-PO4
4 (Fig. 5A) and exhib-
ited a Hex:Hex-PO4 ratio of 4.2:1. In contrast, L. mexicana
aPPG contained both Gal-PO4
4 and Glc-PO4
4 (Fig. 5B) at a
ratio of 1.4:1, and its Hex:Hex-PO4 ratio was 2.6:1.
L. mexicana aPPG Contains Conserved and Novel Monophos-
phorylated Glycans and Novel Di- and Triphosphorylated Oli-
gosaccharides—HPAE-HPLC of mild acid-released aPPG gly-
cans resulted in a variety of peaks in the region of the salt
gradient where monophosphorylated glycans are expected to
elute (Mono-P region, Fig. 3C). A further increase in salt con-
centration eluted two unresolved glycan peak areas (Di-P and
Tri-/Tetra-P region, Fig. 3C) that are not observed in L. mexi-
cana LPG and sAP (compare Fig. 3, A and B). All the aPPG
phosphorylated glycans (Fig. 3C) were sensitive to AP, and the
2 The hexose fraction from 40% HF-treated intact aPPG contained
exclusively mannose, whereas the respective fraction of mild acid-
treated aPPG showed 83% Man, 6% Gal, and 11% Glc. The latter
treatment can lead to some limited hydrolysis of glycosidic bonds in
LPG with concomitant release of pentoses and hexoses (45), whereas
40% HF seems to be more selective for phosphate esters. Therefore, it
appears likely that in intact aPPG, only Man of the hexose fraction is
engaged in labile phosphodiester bonds via its anomeric hydroxyl
group.
3 b-Glucosidase from sweet almonds cleaves terminal b-Glc residues.
It can also cleave terminal b1–3-galactosides (e.g. Galb1–3Galb1–
4Man or Galb1–3Galb1–3Galb1–4Man) but not Galb1–4Man (Ref. 2
and this study).
4 Gal-PO4 and Glc-PO4 from sAP and aPPG coelute in HPAE-HPLC
with authentic Gal-6-PO4 and Glc-6-PO4, but since the elution behavior
of Gal/Glc-2-PO4, -3-PO4, and -4-PO4 on a Carbo-Pac PA1 column is not
known, a definite assignment by this method cannot be made. For the
different Man-PO4, however, it has been shown that Man-6-PO4 is well
separated from Man-2-PO4, -3-PO4, and -4-PO4 (65).
FIG. 4. HPAE-HPLC of total aPPG glycans released by 40% HF
dephosphorylation. Neutral glycans from 40% HF-treated aPPG
were resolved on a Carbo-Pac PA1 column using program 3 before (A)
and after BTBG (B) or SABG (C) treatment. * depicts carbohydrate
peaks, which were not characterized in detail due to their low abun-
dance and/or their complexity.
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corresponding dephosphorylation products coeluted with the
neutral glycans N2b, N3b-c, N4b-c, N5b-d, and N6b-c (Fig. 6A).
The structures of these glycan backbones were confirmed by
ES-MS of permethylated samples and methylation linkage
analysis (Table II). The much higher complexity and the pres-
ence of novel structures in L. mexicana aPPG versus LPG were
also apparent in the comparison of the ES-MS (M 2 H)2
pseudomolecular ions of mild acid hydrolysates. Whereas LPG
gave rise only to the expected ions for Hex2P and Hex3P (not
shown), aPPG showed, in addition, ions for phosphorylated
tetra- and pentasaccharides (Hex4P and Hex5P, Fig. 7A). Sur-
prisingly the most abundant molecular species in ES-MS of
aPPG corresponded to novel diphosphorylated tetrasaccharides
(Hex4P2, Fig. 7A). In addition diphosphorylated pentasaccha-
rides (Hex5P2) and triphosphorylated pentasaccharides
(Hex5P3) were detected (Fig. 7A).
Monophosphorylated aPPG Glycans: Structure of the Major
Components and Identification of Novel Alternative Phospho-
rylation Sites—The major glycans and most of the minor gly-
cans from the relatively well resolved Mono-P glycan region in
HPAE-HPLC (Fig. 3C) were isolated and their structure deter-
mined by a combination of negative ion ES-MS and ES-MS-MS
(Table III, Fig. 8) and coelution on HPAE-HPLC with standard
compounds before and after AP treatment (not shown). These
analyses suggest that the structures of P2 and P3c are PO4-6-
Galb1–4Man and Glcb1–3(PO4-6-Gal)b1–4Man, respectively,
identical to the respective glycans of L. mexicana LPG (39) and
sAP (33). NMR spectroscopy confirmed the structure of P2 (not
shown) and P3c. The downfield signals (at 5.18, 4.89, 4.68, 4.51,
and 4.25 ppm) of the one-dimensional 1H NMR spectrum of P3c
are schematically marked on Fig. 9A and are discussed as a
basis for the interpretation of structurally related but novel
aPPG glycans (see below); the two signals at 5.18 and 4.89 ppm
are assigned to H-1 of the reducing Man residue. The signal at
4.51 ppm is due to H-1 of the phosphorylated Gal residue. The
TOCSY spectrum shows that this signal is part of the same
spin system as the peak at 4.25 ppm which corresponds to the
H-4 shift of the phosphorylated Gal by analogy with P3 from L.
major LPG (43). The small coupling observed on the peak at
4.25 ppm is consistent with a Gal, as H-4 has only gauche
couplings with H-3 and H-5 (in contrast to Glc where H-4 is
axial). A lack of heteronuclear splitting on this peak and its
TABLE I
Positive ion ES-MS, methylation analysis, and exoglycosidase digests of neutral aPPG cap oligosaccharides isolated after mild acid hydrolysis
(Fig. 3C) and aPPG oligosaccharide backbones dephosphorylated by 40% HF treatment (Fig. 4A)
Fraction ES-MS of permethylatedglycans (M 1 Na)1 t-Man t-Glc t-Gal 2-Man 3-Glc 3-Gal 4-Man
Product of
BTBG digest
Product of
SABG digest
Product of
JBAM digest
Man ND ND ND ND ND ND ND ND R R R
N2aa 477.9 (Hex2) 1 2 1 2 2 R R Hex
(1N2b) (1) (1) (S) (R) (R)
N2b 477.8 (Hex2) 2 2 1.2 2 2 2 1.0 Hex R R
N3a 681.8 (Hex3) 1.0 2 2 2.0 2 2 2 R R Hex
N3c 681.8 (Hex3) 2 1.1 2 2 2 0.6 1.0 R N2b R
N4a 885.9 (Hex4) 1.0 2 2 2.0 2 2 2 R R Hex
N4b 885.9 (Hex4) 2 2 1.0 0.5 0.6 1.0 N3c N2b
b R
N4c 885.8 (Hex4) 2 1.2 2 0.5 0.5 1.0 R N2b R
N5aa 1090.0 (Hex5) 1.0 2 4.5 2 R R Hex
(1N3b) (1681.9 (Hex3)) (0.6) (0.5) (0.3) (S) (S) (R)
N5b 1089.8 (Hex5) 2 2 1.1 2 1.4 0.8 1.0 N4c N2b
b R
N5c 1089.9 (Hex5) 2 1.3 2 2 0.8 1.5 1.0 R N2b
b R
N5d 1089.8 (Hex5) 2 1.5 2 2 1.5 1.0 1.0 R N2b R
N6a 1293.8 (Hex6) 1.0 2 2 5.9 2 2 2 R R Hex
N6b 1293.8 (Hex6) 2 1.5 2 2 1.4 1.5 1.0 R N2b
b R
N6c 1293.8 (Hex6) 2 0.9 2 2 1.2 1.7 1.0 R N2b
b R
a N2a and N5a isolated by HPAE-HPLC contained N2b and N3b, respectively; R 5 resistant; S 5 sensitive, but product not determined; 1 5
detected, but not quantitated; 2, not detected; ND, not done.
b See Footnote 3.
TABLE II
Proposed structure and relative abundance of L. mexicana LPG and aPPG glycans released by 40% HF dephosphorylation and isolated by
HPAE-HPLC
Glycan Proposed structure LPG relativeabundancea
aPPG relative
abundancea
Hex 6 (Glc 1 Man) 18.5 (Man)
N2a Mana1–2Man 1.5 1.0
N2b Galb1–4Man 65.5 12.5
N3a (Mana1–2)2Man 1.0 1.0
N3b Galb1–3Galb1–4Man 0.7
N3c Glcb1–3Galb1–4Man 25.0 6.5
N4a (Mana1–2)3Man Trace 1.0
N4b Galb1–3Glcb1–3Galb1–4Man 10.5
N4c Glcb1–3Glcb1–3Galb1–4Man 36.0
N5a (Mana1–2)4Man Trace 0.9
N5b Galb1–3Glcb1–3Glcb1–3Galb1–4Man 3.0
N5c Glcb1–3Hexb1–3Hexb1–3Galb1–4Manb 1.0
N5d Glcb1–3Glcb1–3Glcb1–3Galb1–4Man 3.5
N6a (Mana1–2)5Man 0.5
N6b Glcb1–3(Hexb1–3)3Galb1–4Man
c 0.4
N6c Glcb1–3(Hexb1–3)3Galb1–4Man
c 0.3
a Percent detector response (PAD) in HPAE-HPLC of mild acid-treated LPG and aPPG, respectively.
b One Hex is Glc, and one Hex is Gal.
c Two of the Hex are Glc, and one Hex is Gal.
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downfield shift (;0.06 ppm from H-4 in neutral glycans (43)) is
also consistent with phosphorylation at C-6. The remaining
anomeric signal at 4.68 ppm with a large coupling is assigned
to the terminal b-Glc residue (33, 43).
Remarkably some aPPG-specific monophosphorylated gly-
cans exhibited novel phosphorylation on alternative positions
of the same glycan as follows: P4c9 and P4c (Fig. 3C) both
yielded N4c after dephosphorylation suggesting that they have
the same neutral glycan backbone. ES-MS-MS sequencing of
P4c (Table III, Fig. 8) resulted in a relative intensity of frag-
mentations very similar to that of L. major P4b (Table III, Fig.
8; Galb1–3Galb1–3(PO4-6-Gal)b1–4Man (43)), which indicates
either the sequence Hex-Hex[PO4-Hex]Hex or Hex[PO4-Hex]
Hex-Hex.5 Although P4c9 has the same fragmentation ions as
P4c, their relative distribution was different. In particular a
much stronger fragment ion 259 in ES-MS-MS experiments (25
versus 3%, Fig. 7B and Table III) is indicative of a terminal
position of PO4-Hex in P4c9, either (PO4-Hex)Hex-Hex-Hex or
Hex-Hex-Hex(PO4-Hex). The alternative sequences shown
above are indistinguishable by MS-MS.5 However, the absence
of Man-PO4 in aPPG (Fig. 5B) taken together with methylation
and exoglycosidase analysis and the finding that P4c9 is resist-
ant to SABG, while P4c is degraded to P2,6 suggest the struc-
tures PO4-Glcb1–3Glcb1–3Galb1–4Man for P4c9 and Glcb1–
3Glcb1–3-(PO4-Gal)b1–4Man for P4c. This interpretation was
corroborated and extended by 1H NMR studies which estab-
lished that the phosphorylation sites were at the C-6 of Gal in
P4c and C-6 of Glc in P4c9; the anomeric region of the NMR
spectrum for each of these monophosphorylated tetrasacchar-
ides is shown in Fig. 9. This region of the spectrum of P4c (Fig.
9A) is similar to that of P3c (whose shifts are marked on Fig.
9A) except for the presence of an additional anomeric signal5 Attempts to resolve this question by reduction of P4c9 and P4c with
NaBD4 (2 M NH3, 1 M NaBD4, 12 h, 4 °C) were unsuccessful, because the
complex ES-MS-MS fragmentation patterns obtained after reduction
suggested that phosphate migration had occurred under the alkaline
conditions. Similar observations were made with the diphosphorylated
glycans (T. Ilg and G. Currie, unpublished results). Therefore the as-
signment of the sequence relies on the fact that no Man-6-PO4 was
detected in aPPG (see Fig. 5). Thus the hexose at the reducing end (i.e.
Man) cannot be phosphorylated.
6 b-Glucosidase from sweet almonds contains low amounts of a con-
taminating acid phosphatase, which converts P4c9 and P4c into N4c.
N4c is then rapidly degraded to N2b by the glycosidase. However, short
term incubations of P4c result in the formation of P2, whereas no P2
formation is observed with P4c9. Interestingly, P4c9 also seems to be
more resistant to the contaminating phosphatase than P4c.
FIG. 5. Determination of the hexose and hexose phosphate
content of L. mexicana sAP and L. mexicana aPPG by HPAE-
HPLC and GC-MS. Hexoses and hexose phosphates were released by
2 M trifluoroacetic acid treatment and separated on a Carbo-Pac PA1
column using gradient program 8. A, L. mexicana sAP; B, L. mexicana
aPPG. Hexoses and, after dephosphorylation with AP, hexose phos-
phates were analyzed and quantitated as alditol acetates by GC-MS. #,
the results of the hexose analysis are normalized to 50 mannose resi-
dues; * is a gradient spike.
FIG. 6. HPAE-HPLC of AP-treated total phosphorylated,
diphosphorylated, and triphosphorylated aPPG glycans. A, total
phosphorylated glycans were purified by HPAE-HPLC of mild acid-
released aPPG glycans on a Carbo-Pac PA1 column using gradient
program 4 (peak eluting at 1 M sodium acetate, not shown). After AP
treatment the neutral glycans were separated on a Carbo-Pac PA1
column using gradient program 1. B and C, diphosphorylated glycans
(compare Fig. 3D) and triphosphorylated glycans (compare Fig. 3E),
respectively, were also treated with AP and separated on a Carbo-Pac
PA1 column using gradient program 1. # depicts non-carbohydrate
peaks; * depicts carbohydrate peaks, which were not characterized in
detail due to their low abundance and/or their complexity.
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corresponding to the extra Glc residue (d 5 4.77 ppm, J 5 7.5
Hz). Phosphorylation at C-6 of the Gal residue is confirmed
from the characteristic shift of Gal H-4. By contrast, this peak
is shifted upfield in P4c9, indicating that Gal C-6 is not phos-
phorylated in this isomer. Phosphorylation in this case is at C-6
of a Glc residue as deduced by the appearance of two multiplets
at 4.15 and 4.05 ppm, corresponding to the separate 6-CH2
protons of this Glc residue (Fig. 9B). In addition to the MS
evidence noted above, phosphorylation at the terminal Glc is
supported by a 0.02 ppm upfield shift for H-1 of the terminal
Glc in P4c9 relative to P4c but no change in the H-1 shift of the
nonphosphorylated penultimate Glc residue.
Of the minor glycans, the monophosphorylated pentasaccha-
ride P5d (Table IV) resulted in N5d after dephosphorylation,
whereas its ES-MS-MS spectrum was very similar to the spec-
trum of P5b from L. major LPG (Table III, Fig. 8, Galb1–
3Galb1–3Galb1–3(PO4-6-Gal)b1–4Man, (43)). Therefore we
tentatively assign the phosphate to the Gal residue in P5d
(Glcb1–3Glcb1–3Glcb1–3(PO4-Gal)b1–4Man, Table IV). An-
other minor component, the monophosphorylated trisaccharide
P3b (Fig. 3C), gave rise to N3b (Table II) after enzymatic
dephosphorylation. Coelution with an authentic standard from
L. major LPG suggests that its structure may be Galb1–3(PO4-
6-Gal)b1–4Man. Dephosphorylation of P3c9 yielded N3c, the
same product as obtained from P3c (not shown). However,
although the ES-MS-MS spectra of P3c derived from either
aPPG or sAP were very similar, the spectrum of P3c9 was quite
distinct and showed an abundant fragment ion of 259 atomic
mass units, indicative of a terminal position of PO4-Hex (Table
III, Fig. 8). These results suggest that P3c9 is PO4-Glcb1–
3Galb1–4Man, a phosphoisomer of P3c. For the monophospho-
rylated tetrasaccharide P4b9, N4b was identified as glycan
backbone (Table II). Its ES-MS-MS spectrum was similar to the
spectrum of P4c9 which suggests the structure PO4-Galb1–
3Glcb1–3Galb1–4Man (Table III, Fig. 8). Two other peaks
(eluting on a Carbo-Pac PA1 column between P4b9 and P4c9,
Fig. 3C) were identified as monophosphorylated tetrasaccha-
rides by ES-MS (Table IV), but insufficient amounts of material
precluded more detailed studies.
Structure of Novel Diphosphorylated aPPG Glycans—ES-MS
of the unresolved aPPG glycans eluting in the first large peak
under high salt conditions in HPAE-HPLC (Di-P, Fig. 3C)
revealed two major ion species corresponding to the novel
diphosphorylated glycans Hex4P2 and Hex5P2 (not shown, see
also Fig. 7A). After dephosphorylation the neutral glycan back-
bones were purified by HPAE-HPLC (Fig. 6B) and analyzed by
positive ion ES-MS of the permethylated glycans as well as by
methylation linkage analysis. The major oligosaccharide corre-
sponded to N4c, whereas minor glycan backbones were N4b,
N5b, and N5d (Table II). Individual diphosphorylated glycans
were separated by HPAE-HPLC under isocratic conditions.
Three glycans were obtained in a purified form (.90%), Di-P4b,
Di-P4c, and Di-P5b (Fig. 3D), whose dephosphorylation prod-
ucts corresponded to N4b, N4c, and N5b, respectively (Table
II). The main fragmentation series in ES-MS-MS (Fig. 7C, Fig.
8, and Table III) together with the absence of Man-PO4 in the
FIG. 7. Negative ion ES-MS and ES-MS-MS of native phospho-oligosaccharides from L. mexicana aPPG. A, ES-MS spectrum of total
aPPG phospho-oligosaccharides released by mild acid hydrolysis. The molecular ions (M 2 H)2, (M 2 2H)22, and (M 2 2H 1 Na)2 are indicated;
B, ES-MS-MS of P4c9; C, ES-MS-MS of Di-P4c; D, ES-MS-MS of Tri-P5d. B–D, daughter ions of the molecular ions and the proposed fragmentation
are shown. Ions arising from the loss of H2O (218 atomic mass units), C2O2H4 (260 atomic mass units), C2O3H6 (278 atomic mass units), and
H3PO4 (298 atomic mass units) are indicated.
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hexose phosphate analysis (Fig. 5B) suggested the structures
PO4-Galb1–3Glcb1–3(PO4-Gal)b1–4Man for Di-P4b and PO4-
Glcb1–3Glcb1–3(PO4-Gal)b1–4Man for Di-P4c (Table IV).
These results were confirmed and extended by 1H NMR, 31P
NMR, and HMBC spectroscopy on Di-P4b9 and Di-P4c (Fig. 9,
C–F). Phosphorylations at C-6 of both the Gal residue and the
terminal Glc in Di-P4c are indicated by the characteristic
downfield shift of Gal H-4 (4.25 ppm) and the two multiplet
signals for the 6-CH2 protons of the terminal Glc (Fig. 9C) at
4.05 and 4.18 ppm. These two multiplets simplify on 31P de-
coupling, confirming a Glc-6-CH2-O-P linkage. The Di-P4b gly-
can is different from Di-P4c in that the terminal Glc is replaced
by Gal. As expected, the characteristic Glc-6-CH2-O-P proton
signals are missing from the Di-P4b spectrum (Fig. 9D). The
HMBC spectra of these two diphosphorylated derivatives (Fig.
9, E and F), which show cross-peaks only for those protons
which have a long range spin-spin coupling interaction with
31P nuclei (in this case three bond couplings, compare Ref. 34),
confirm these proposed assignments. For Di-P4b two signals
are detected, with 31P shifts characteristic of monoester phos-
phate groups and 1H shifts characteristic of Gal 6-CH2. These
signals occur at 4.02 and 3.98 ppm for the two Gal residues,
each corresponding to two near-degenerate CH2 chemical shifts
(Fig. 9F). By contrast, in Di-P4c the individual Glc-6-CH2 pro-
tons have different chemical shifts, and this leads to two sig-
nals (each split by H-H coupling) as indicated in Fig. 9E. The
Gal-6-CH2 protons remain close to degenerate and yield a sin-
gle cross-peak. The fact that a single 31P nucleus yields HMBC
cross-peaks to two protons unequivocally confirms the phos-
phorylation site for the terminal Glc to be at 6-CH2 rather than
at one of the ring positions, which have only single protons.
It should be noted that the ES-MS-MS spectrum of both
Di-P4b and Di-P4c showed also fragment ions of Hex2P2 (483
and 501 atomic mass units) (Table III). This suggests that the
phosphoisomer PO4-Hexb1–3(PO4-Hex)b1–3Hexb1–4Hex is
also present in Di-P4b and Di-P4c. However, NMR spectros-
copy does not indicate phosphate position heterogeneity in the
two glycans (Fig. 9). If present, components phosphorylated at
the penultimate Glc would readily be detected in the spectrum
of the Di-P4b fraction via signals in the region 4.00–4.20 ppm
but none are present at a detection limit of ,5%. Similarly,
minor components phosphorylated at the penultimate Glc
would be detected in the Di-P4c fraction as slightly shifted Glc
H-1 signals, and none are present at this detection limit. Al-
though the presence of small amounts of the respective PO4-
Hexb1–3(PO4-Hex)b1–3Hexb1–4Hex compound cannot be
completely ruled out in Di-P4b and Di-P4c, a more likely ex-
planation for the fragment ions 483 and 501 atomic mass units
could be intramolecular migration of PO4 in ES-MS prior to
fragmentation. Intramolecular PO4 migration from Hex to Hex
in oligosaccharides has been observed by us after incubation in
mildly alkaline solutions.5,7
The main fragmentation pattern of negative ion ES-MS-MS
on Di-P5b (Table III and Fig. 8) and the results of hexose
phosphate analysis are consistent with the structure PO4-
Galb1–3Glcb1–3Glcb1–3(PO4-Gal)b1–4Man (Table IV). Since
the ES-MS-MS spectrum of the molecular ion 987.5 atomic
mass units of the pooled diphosphorylated glycans was very
7 Intramolecular phosphate migration in the gas phase may also
explain the occurrence of low amounts of the “unexpected” fragment
ions 241 and 259 atomic mass units in negative ion ES-MS-MS of P4b
and P5b of L. major LPG, P3c of L. mexicana LPG and sAP, P3c and P4c
of L. mexicana aPPG (Table III and Fig. 7), as well as the low amount
of unexpected ions identified in all other samples investigated in this
study (Table III and Fig. 7).
TABLE III
ES-MS-MS of phosphorylated oligosaccharides isolated from L. mexicana (L. mex.) aPPG, sAP, and L. major (L. maj.) LPG
The relative abundance of fragment ions is normalized to the base ion of the respective ESI-MS/MS-spectrum (5100). The masses of the fragment
ions are indicated in atomic mass units.
* Depicts ions arising from the loss of 98 (H3PO4), 80 (H2PO3), 78 (C2O3H6), 60 (C2O2H4), and 18 (H2O).
** ES-MS-MS of these glycans was performed on the doubly negatively charged molecular ion (M-2H)2.
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similar to that of Di-P5b (Table III), it can be assumed that
Di-P5d has the structure PO4-Glcb1–3Glcb1–3Glcb1–3(PO4-
Gal)b1–4Man (Table IV). Similarly as for Di-P4b and Di-P4c,
low levels of ions indicative for terminal Hex2P2 (483 and 501
atomic mass units) and Hex3P2 (645 and 663 atomic mass
units) were found in both spectra (Table III) that may have
been formed by PO4 migration in ES-MS prior to fragmentation
(see above).5,7
Structure of Triphosphorylated Glycans and Evidence for
Tetraphosphorylated Glycans—The aPPG glycans of the second
HPAE-HPLC high salt peak (Tri- and Tetra-P, Fig. 3C) were
rechromatographed to remove residual diphosphorylated gly-
cans and to resolve the triphosphorylated glycans (Tri-P, Fig.
3E) from other components. ES-MS on the pooled triphospho-
rylated glycans revealed three major ions corresponding to
Hex4P3 (905.8 atomic mass units), Hex5P3 (1068.5 atomic mass
units), and Hex6P3 (1229.7 atomic mass units) (not shown,
compare also Fig. 7A). After dephosphorylation, N4c, N5b, N5c,
N5d, N6b, and N6c (Table II) were detected in HPAE-HPLC
(Fig. 6C), and their structures were confirmed by methylation
analysis. The ES-MS-MS fragmentation pattern of Tri-P4c
from the native glycan mixture (Table III and Fig. 8) was
consistent with the structure PO4-Glcb1–3(PO4-Glc)b1–3(PO4-
Gal)b1–4Man (Table IV). Partial purification of the pooled
glycans yielded three fractions (fractions 1–3, Fig. 3E). Frac-
tion 3 contained mainly Tri-P5d and only small amounts of
Tri-P6b as shown by AP digestion followed by HPAE-HPLC
(not shown). ES-MS-MS on Tri-P5d (Table III and Fig. 8), the
results of the hexose phosphate analysis and methylation anal-
ysis indicated the structure PO4-Glcb1–3(PO4-Glc)b1–3Glcb1–
3(PO4-Gal)b1–4Man. ES-MS-MS spectra of the Hex5P3
2 molec-
ular ion of the mixture of triphosphorylated glycans or fractions
enriched for either Tri-P5b or TriP5c (relative abundance, frac-
tion 2: Tri-P5b 5 TriP5c; fraction 1: Tri-P5b . Tri-P5c) were
very similar to that of Tri-P5d (Table III and Fig. 8), suggesting
that the structures of Tri-P5b and Tri-P5c could be PO4-Galb1–
3(PO4-Glc)b1–3Glcb1–3(PO4-Gal)b1–4Man and PO4-Glcb1–
3(PO4-Hex)b1–3Hexb1–3(PO4-Gal)b1–4Man, respectively.
The fragment ions for Hex3P3 (725 and 743 atomic mass units)
that were present in all Tri-P5 spectra at low abundance (Table
III) were most likely PO4 migration products as discussed
above for the Di-P glycans.5,7
Tri-P6b (highly enriched in fraction 1) showed an ES-MS-MS
spectrum (Table III and Fig. 8) suggestive of either the se-
quence PO4-Hex-Hex-(PO4-Hex)Hex-(PO4-Hex)-Hex or PO4-
Hex-Hex-Hex-(PO4-Hex)-(PO4-Hex)-Hex (Table IV), which are
indistinguishable by MS. ES-MS-MS on a mixture of Tri-P6b
and Tri-P6c oligosaccharides yielded fragment ions of the same
type and similar abundance as Tri-P6b alone, which suggests a
FIG. 8. Proposed negative ion ES-MS-MS fragmentation patterns of phosphorylated oligosaccharides isolated from L. mexicana
aPPG, LPG and L. major LPG. The masses of the daughter ions are indicated in atomic mass units, and their relative abundance is summarized
in Table III.
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similar distribution of the phosphates on the hexoses of the
oligosaccharide chain in both compounds (Tables III and IV)
In HPAE-HPLC of the triphosphorylated glycans, an addi-
tional peak eluting later in the gradient was observed (Tetra-P,
Fig. 3E). Negative ion ES-MS of this peak yielded ions indica-
tive of tetraphosphorylated glycans. The ES-MS-MS fragmen-
tation pattern of the two most abundant molecular species
Hex7P4 (1471.5 amu) and Hex8P4 (1634.5 atomic mass units) is
shown in Table III. Whereas the fragmentation of Hex7P4 is
consistent with the structure P-Hex-Hex-(P-Hex)-(P-Hex)-Hex-
(P-Hex)-Hex containing only phosphomonoesters (Table IV,
compare Fig. 8), Hex8P4 is most likely composed of two diphos-
phorylated tetrasaccharides linked together by a phosphodi-
ester bond (compare Fig. 8). The high abundance of the frag-
ment ions 825 and 807 atomic mass units (Table III), which
could arise from a preferred cleavage of the labile phosphodi-
ester, is consistent with the proposed structure.
1H and 31P NMR Spectroscopy on Intact aPPG—The one-
dimensional 1H and 31P NMR spectra, 31P-1H HMBC spectra of
L. mexicana aPPG in D2O, and for comparison some corre-
sponding spectra of L. mexicana LPG are shown in Fig. 10. The
assignments in the displayed region of the 1H NMR spectrum
of aPPG (Fig. 10A) are based on the accumulated information
from the component glycans, the HMBC spectra, and relevant
literature data with one exception. In the one-dimensional 1H
NMR spectrum the peak at 5.30 ppm is similar to one previ-
ously assigned to Mana1-PO4 in sAP based on comparison with
earlier shifts (33). However it appears likely that this assign-
ment was incorrect. Acquisition of the spectrum of aPPG in the
presence of 31P decoupling produced no change in the line
shape of this peak, indicating that no heteronuclear coupling is
present in this multiplet. The peak instead corresponds to H-1
signals from 2-Mana1- residues. The unsubstituted Mana1-
PO4 anomeric signal, which must be of relatively large inten-
sity based on the composition data in Table IV, appears to be
superimposed with that of 4-Mana1-PO4.
Typical 31P NMR chemical shifts of phosphomonoesters are
around 3.5–4.5 ppm, while phosphodiester exhibit shifts ap-
proximately 1.0 ppm. The 31P NMR spectra of aPPG and LPG
(Fig. 10B) are characteristic of diester phosphates, and no
monoester peaks were detected (,2%). For LPG a single peak
envelope is observed in the one-dimensional 31P NMR spec-
FIG. 9. NMR spectroscopy of phospho-oligosaccharides isolated from mild acid-hydrolyzed L. mexicana aPPG. Anomeric region of
the 1H NMR spectra of phosphorylated tetrasaccharides; A, P4c; B, P4c9; C, Di-P4c; D, Di-P4b. The chemical shifts of corresponding signals in P3c
are shown as filled circles in A. E and F are HMBC spectra of Di-P4c and Di-P4b, respectively. The splitting of the two inequivalent CH2 signals
for Glc-6-PO4 is indicated in E.
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trum, which indicates that the multiple 31P nuclei present all
have close to the same chemical environment. For aPPG the
31P NMR peak is much broader and contains a discernible
shoulder, suggesting a superimposition of different 31P envi-
ronments (Fig. 10B). This is confirmed in the HMBC spectrum
(Fig. 10C); the advantage of this two-dimensional representa-
tion is that the various phosphorous environments are partially
resolved by the chemical shift of their J-coupled protons. Three
distinct 31P shifts (1.10, 1.18, and 1.35 ppm) are resolved based
on non-overlapped proton shifts and correlate with the 1H shift
of 6-CH2-Gal (4.08 ppm), the
1H shift of H-1 of 2-Mana1-PO4
(5.68 ppm), and with the 1H shifts of the non-degenerate
6-CH2-Glc protons (4.10 and 4.20 ppm), respectively. The
strongest cross-peak in the HMBC spectrum has a single 1H
chemical shift corresponding to the overlapped H-1 signals of
4-Mana1-PO4 and unsubstituted Mana1-PO4 but is split into
two components of approximately equal intensity in the 31P
dimension. As the two components have 31P shifts correspond-
ing to -PO4-6-Gal (1.10 ppm) and -PO4-6-Glc (1.35 ppm), the
most likely explanation for the splitting is due to the different
31P environments brought about by a linkage to the respective
monosaccharide via the phosphodiester bond. The alternative
explanation of the two 31P components reflecting differences on
the other side of the phosphodiester bond (Mana1- versus 24-
Mana1-) is less likely since the environmental differences be-
tween these two groups as far as the phosphodiester bond is
concerned is very small, as demonstrated by their coincident
H-1 1H shifts. There was no evidence for the presence of PO4-2-,
PO4-3-, or PO4-4-Hex in intact aPPG (less than 2% relative to
4-Mana1-PO4 1 Mana1-PO4), which suggests that R-Mana1-
PO4-6-Gal-R and the novel linkage R-Mana1-PO4-6-Glc-R are
the predominant, possibly exclusive, phosphodiester types link-
ing the glycans of this compound. In contrast to aPPG, the
HMBC spectrum of LPG shows essentially only a single 31P
environment. This reflects the absence of PO4-6-Glc in LPG
(39), whereas the expected HMBC signals of 2-Mana1-PO4,
4-Mana1-PO4, and PO4-6-Gal are present (Fig. 10D).
DISCUSSION
Previous studies have shown that Leishmania promastigotes
synthesize lipid-bound (LPG), free (PG), and protein-bound
(sAP, pPPG) phosphoglycan antigens, which may play crucial
roles for virulence and transmission of this parasite life stage
(1, 3, 5, 46, 47). In the amastigote form, which causes disease in
TABLE IV
Proposed structure and relative abundance of glycans released from L. mexicana aPPG by mild acid hydrolysis and isolated by HPAE-HPLC
(see Figs. 3, 4, and 6) and negative ion ES-MS (see Figs. 7 and 8 and Table III)
NA, not applicable; ND, not determined; amu, atomic mass units.
Fraction Native glycans([M-H], amu) Proposed structure
Relative
abundancea
Neutral cap glycans: S,41.4
Hex NA Man 15.3
N2a NA Mana1–2Man 2.3
N2b NA Galb1–4Man 8.1
N3a NA (Mana1–2)2Man 2.3
N3b NA Galb1–3Galb1–4Man 0.8
N3c NA Glcb1–3Galb1–4Man 4.2
N4a NA (Mana1–2)3Man 1.8
N4b NA Galb1–3Glcb1–3Galb1–4Man 1.2
N4c NA Glcb1–3Glcb1–3Galb1–4Man 3.5
N5a NA (Mana1–2)4Man 1.2
N6a NA (Mana1–2)5Man 0.7
Mono-phosphorylated glycans S,32.7
P2 421.7 PO4-6-Galb1–4Man 9.7
P3b 583.5 Galb1–3[PO4-6-Gal]b1–4Man 1.0
P3c9 583.5 PO4-6-Glcb1–3Galb1–4Man 1.0
P3c 583.5 Glcb1–3[PO4-6-Gal]b1–4Man 5.8
P4b9 745.6 PO4-6-Galb1–3Glcb1–3Galb1–4Man 1.0
P4c9 745.6 PO4-6-Glcb1–3Glcb1–3Galb1–4Man 6.8
P4c 745.6 Glcb1–3Glcb1–3[PO4-6-Gal]b1–4Man 5.5
P5d 907.6 Glcb1–3Glcb1–3Glcb1–3[PO4-6-Gal]b1–4Man 1.0
Others (745.6) PO4-(Hex)4 .0.9
Di-phosphorylated glycans S,23.1
Di-P4b 825.5 PO4-6-Galb1–3Glcb1–3[PO4-6Gal]b1–4Man 4.6
Di-P4c 825.5 PO4-6-Glcb1–3Glcb1–3[PO4-6Gal]b1–4Man 16.8
Di-P5b 987.8 PO4-6-Galb1–3Glcb1–3Glcb1–3[PO4-6-Gal]b1–4Man 1.2
Di-P5d 987.8 PO4-6-Glcb1–3Glcb1–3Glcb1–3[PO4-6-Gal]b1–4Man 0.5
Tri-phosphorylated glycans S,.2.8
Tri-P4c 905.8 PO4-6-Glcb1–3[PO4-6-Glc]b1–3[PO4-6-Gal]b1–4Man 0.5
Tri-P5b 1067.3 PO4-6-Galb1–3[PO4-6-Glc]b1–3Glcb1–3[PO4-6-Gal]b1–4Man 0.5
Tri-P5c 1067.3 PO4-6-Glcb1–3[PO4-6-Hex]b1–3Hexb1–3[PO4-6-Gal]b1–4Man
b ,0.3
Tri-P5d 1067.3 PO4-6-Glcb1–3[PO4-6-Glc]b1–3-Glcb1–3[PO4-6-Gal]b1–4Man 1.8
Tri-P6b 1229.7 PO4-6-Glcb1–3Hexb1–3[PO4-6-(Hexb1–3Hex)]b1–3[PO4-6-
Gal]b1–4Manc,d
,0.3
Tri-P6c 1229.7 PO4-6-Glcb1–3Hexb1–3[PO4-6-(Hexb1–3Hex)]b1–3[PO4-6-
Gal]b1–4Manc,d
,0.3
Tetra-phosphorylated glycans S,,0.6
Tetra-P7 1471.5 PO4-Hex[PO4-Hex]Hex[PO4-Hex]Hex[PO4-Hex]Hex ND
a Percent detector response in HPAE-HPLC of mild acid-treated aPPG.
b One Hex is Glc; one Hex is Gal.
c Two of the Hex are Glc; one Hex is Gal.
d The position of the second phosphate residue is ambiguous. It could be located on either the third or the fourth Hex. NA: not applicable.
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the mammalian host, LPG expression is strongly down-regu-
lated (23–25, 48), in most species to undetectable levels (21,
22). However, L. mexicana amastigotes do synthesize large
amounts of a stage-specific proteophosphoglycan (aPPG) (22,
35). In this study we have elucidated the main structural
features of this novel parasite antigen; aPPG consists of a
defined polypeptide backbone, which is modified by a variety of
carbohydrate structures via Ser(P) residues. We demonstrate
that aPPG contains all glycans previously identified in L. mexi-
cana promastigote phosphoglycan antigens LPG and sAP (33,
39), which include mannose, the manno-oligosaccharide series
N2a-6a and N2b, P2 and P3c (Table IV). However, the majority
of the glycans (Tables II and IV) have not been detected previ-
ously in L. mexicana (N3b, P3b, P4c) or represent completely
novel structures (N4b, N4c, P3c9, P4b9, P4c9, P5d, Di-P4b, Di-
P4c, Di-P5b, Di-P5d, Tri-P4c, Tri-P5b, Tri-P5c, Tri-P5d, Tri-
P6b, Tri-P6c, and Tetra-P7, Tables II and IV). Another surpris-
ing feature of aPPG is the presence of phosphoisomers of some
monophosphorylated glycans (P3c9 versus P3c and P4c9 versus
P4c) and the presence of novel multiphosphorylated glycans.
These glycans are phosphorylated at the 6-position of either
Gal or Glc residues, or both. To our knowledge, Glc-6-P has not
been previously observed in glycoconjugates from any source.
Neither the promastigote phosphoglycan antigens from L.
mexicana (LPG and sAP, this study; PG and pPPG)8 nor from
promastigotes of other Leishmania species (L. major LPG, PG,
pPPG and L. donovani LPG, PG, sAP)8 contain the novel struc-
ture elements described above. The neutral and phosphoryl-
ated glycans are linked by phosphodiester bonds of the con-
served structure R-Mana1-PO4-6-Gal-R and the newly
identified linkage R-Mana1-PO4-6-Glc-R (compare Fig. 11).
Taken together, our results suggest that the aPPG glycans
8 T. Ilg, unpublished results.
FIG. 10. NMR spectroscopy of native L. mexicana aPPG and LPG. A, anomeric region of the 500 MHz 1H NMR spectrum of aPPG at 288
K. The 1H NMR spectrum was recorded at 288 K to avoid overlap of the residual solvent signal with the anomeric protons marked I. The
assignments for well resolved peaks are indicated. The peak envelopes I–III contain many overlapping signals, including the following: I, t-Glcb1.3-
(33), t-Galb1.3- (34, 43), and based on the shifts for the isolated glycans in Fig. 9, 3-Glcb1.3-, 3-[PO4-6-Glcb1.3-], PO4-6-Galb1.3-, and PO4-6-
Glcb1.3-; II, 3-Galb1.4 and 3-[PO4-6-Galb1.4-]; III, PO4-6-Galb1.4-], t-Galb1.4-. B,
31P NMR spectrum of aPPG at 298 K. The lower trace is the
corresponding 31P spectrum of L mexicana LPG; C and D are HMBC spectra of aPPG and LPG, respectively.
FIG. 11. Schematic model for L. mexicana aPPG. The model
depicts possible structural arrangements of some of the aPPG oligosac-
charides listed in Table IV. On average, each glycan chain is composed
of 6 phospho-oligosaccharides and 4 terminating cap structures. The
glycan chains are linked to the protein core via Ser(P). However, the
detailed structure of the individual glycan chains in aPPG and the
degree of site-specific microheterogeneity is unknown.
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could be highly branched chains as proposed in the structure
model shown in Fig. 11. This structural arrangement is quite
distinct from promastigote phosphoglycans like LPG or sAP
(compare Refs. 33 and 39). Based on the results shown in Table
IV, it can be calculated that, on average, each aPPG glycan
chain contains approximately six phosphorylated oligosaccha-
rides, which are capped by four neutral oligosaccharides. These
glycan chains are linked to the protein backbone most likely via
the basic structure R-Mana1-PO4-Ser (compare Fig. 11). How-
ever, the sequence, length, and branching of the glycan chains
on individual glycosylation sites remain to be determined.
In contrast to conventional N- and O-glycosylation via glyco-
sidic linkages to Asn and Ser/Thr, respectively (49), glycosyla-
tion of proteins via phosphoamino acids is much less common.
This type of protein-glycan linkage has only been reported in
the slime mold Dictyostelium discoideum (via Ser(P) (50)) and
in the parasitic protozoa Leishmania (via Ser(P) (33, 34)) and
Trypanosoma cruzi (via Thr(P) (51)) but appears to be absent in
vertebrates. Phosphodiester linkages of the type Mana1-PO4-
6-Man-R are common in cell wall mannoproteins as well as in
vacuolar and secreted enzymes of several yeast species (52, 53
and references therein), whereas similar linkages in glycans of
vertebrates are very rare (54–56). The phosphodiester-linked
glycan structures of Leishmania aPPG are different and far
more complex. Therefore, the biosynthetic enzymes involved in
the formation of aPPG glycan structures, in particular the
phosphodiester linkages between the glycans and between Ser
and the glycan chains, could be attractive targets for the de-
velopment of specific anti-parasite drugs.
It has been shown recently that aPPG may contribute to the
formation of the huge parasitophorous vacuoles (36), which are
rapidly formed after infection of macrophages (57) and COS
cells (58) by L. mexicana. In these parasite-harboring vacuoles,
aPPG is present in mg/ml concentrations (36). L. mexicana
aPPG is most likely released from the parasitophorous vacuole
upon rupture of infected macrophages and possibly also by
vesicular traffic and exocytosis from the living infected host cell
(35). Released aPPG activates the complement cascade via the
lectin pathway. This unusual complement activation by a sol-
uble parasite product may contribute to the pathology in the
lesion (37). The structural basis for this property of aPPG is
most likely the abundance of potential mannose-binding lectin
binding sites (Mana1-PO4- and (Mana1–2)1–5Mana1-PO4-,
compare Table IV) on the surface of this macromolecule. Other
effects of intra- and extracellular aPPG on the immune func-
tions of infected mice are currently being investigated. In par-
ticular, it appears possible that some of the modulating activ-
ities on signal transduction, lymphokine production, and gene
expression in macrophages described for promastigote LPG (8,
9, 12) in vitro could be mediated in vivo in infected tissue by the
structurally related aPPG.
For aPPG biosynthesis, the expression of several novel gly-
cosyltransferases must be activated in the amastigote. Signals
from the macrophage appear to be essential for the develop-
mental regulation of aPPG expression, since this antigen is not
detected in the culture supernatant of axenic amastigotes.9 The
stage-specific expression of aPPG is another example of the
profound biochemical changes occurring during the L. mexi-
cana transformation of promastigotes into amastigotes, previ-
ously documented for the expression of lysosomal cysteine pro-
teinases (59, 60), the surface/lysosomal metalloproteinase gp63
(22, 61–63), as well as LPG and sAP (22, 46, 64). These dis-
tinctive stage-specific variations most likely reflect an adapta-
tion to the different and more hostile environment of the
phagolysosomal compartment of macrophages.
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